Pantoprazole-associated inflammatory bowel disease reporting signals and altered epithelial inflammatory responsiveness: an integrative pharmacovigilance and experimental study

Background The association between proton pump inhibitor (PPI) use and inflammatory bowel disease (IBD) remains uncertain. We evaluated PPI-associated IBD reporting signals and explored pantoprazole-related molecular and epithelial inflammatory responses. Methods FAERS reports from 2004 to 2024 were analyzed by disproportionality analysis. IBD transcriptomic datasets were integrated with predicted pantoprazole targets, followed by pathway analysis and machine-learning-based gene prioritization. Cell-type distribution was examined in GSE214695. Molecular docking and molecular dynamics simulation were performed to examine the predicted pantoprazole–LCN2 complex. HT29 and NCM460 cells were used for CCK-8 and RT-qPCR validation. For inflammatory challenge, HT29 cells were pretreated with pantoprazole and then exposed to TNF-α. Results Among 148,426 PPI-associated reports, 1,402 involved IBD-related events. Pantoprazole showed the strongest reporting signal (ROR 5.64, 95% CI 5.31–6.00). A total of 109 overlapping candidate genes were identified, and six were prioritized: BACE2, S100A9, SORD, MMP3, LCN2, and SELP. Pantoprazole increased LCN2 mRNA expression in both HT29 and NCM460 cells, and further increased TNF-α-induced IL6 and IL8 mRNA expression in HT29 cells. Conclusion Pantoprazole showed a disproportionate IBD reporting signal in FAERS and altered epithelial inflammatory responsiveness in vitro . These findings do not establish causality and require further epidemiological and mechanistic validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-18
DOI
https://doi.org/10.3389/fphar.2026.1994062
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pantoprazole-associated inflammatory bowel disease reporting signals and altered epithelial inflammatory responsiveness: an integrative pharmacovigilance and experimental study

Shuxun Wei, Caie Wang, Yajun Zhang, Qian-Yu Tian
Frontiers in Pharmacology
Inflammatory Bowel Disease
article

Pantoprazole-associated inflammatory bowel disease reporting signals and altered epithelial inflammatory responsiveness: an integrative pharmacovigilance and experimental study

Shuxun Wei, Caie Wang, Yajun Zhang, Qian-Yu Tian
article en

Abstract

Background The association between proton pump inhibitor (PPI) use and inflammatory bowel disease (IBD) remains uncertain. We evaluated PPI-associated IBD reporting signals and explored pantoprazole-related molecular and epithelial inflammatory responses. Methods FAERS reports from 2004 to 2024 were analyzed by disproportionality analysis. IBD transcriptomic datasets were integrated with predicted pantoprazole targets, followed by pathway analysis and machine-learning-based gene prioritization. Cell-type distribution was examined in GSE214695. Molecular docking and molecular dynamics simulation were performed to examine the predicted pantoprazole–LCN2 complex. HT29 and NCM460 cells were used for CCK-8 and RT-qPCR validation. For inflammatory challenge, HT29 cells were pretreated with pantoprazole and then exposed to TNF-α. Results Among 148,426 PPI-associated reports, 1,402 involved IBD-related events. Pantoprazole showed the strongest reporting signal (ROR 5.64, 95% CI 5.31–6.00). A total of 109 overlapping candidate genes were identified, and six were prioritized: BACE2, S100A9, SORD, MMP3, LCN2, and SELP. Pantoprazole increased LCN2 mRNA expression in both HT29 and NCM460 cells, and further increased TNF-α-induced IL6 and IL8 mRNA expression in HT29 cells. Conclusion Pantoprazole showed a disproportionate IBD reporting signal in FAERS and altered epithelial inflammatory responsiveness in vitro . These findings do not establish causality and require further epidemiological and mechanistic validation.

Frontiers in PharmacologyVol. 17
Henan University of Science and Technology (CN), Second Military Medical University (CN), First Affiliated Hospital of Henan University of Science and Technology (CN), Eastern Hepatobiliary Surgery Hospital (CN)
Good health and well-being
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon